Mesa Laboratories ROE 2011-2025 | MLAB
Current and historical return on equity (ROE) values for Mesa Laboratories (MLAB) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Mesa Laboratories ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-09-30 | $0.00B | $0.18B | -1.20% |
| 2025-06-30 | $0.00B | $0.17B | -0.62% |
| 2025-03-31 | $0.00B | $0.16B | -1.91% |
| 2024-12-31 | $-0.25B | $0.16B | -164.05% |
| 2024-09-30 | $-0.25B | $0.16B | -114.88% |
| 2024-06-30 | $-0.25B | $0.15B | -92.36% |
| 2024-03-31 | $-0.26B | $0.15B | -77.04% |
| 2023-12-31 | $0.00B | $0.40B | 0.25% |
| 2023-09-30 | $0.00B | $0.39B | -0.26% |
| 2023-06-30 | $0.00B | $0.39B | 0.26% |
| 2023-03-31 | $0.00B | $0.39B | 0.26% |
| 2022-12-31 | $0.00B | $0.39B | -0.52% |
| 2022-09-30 | $0.00B | $0.37B | -1.04% |
| 2022-06-30 | $0.00B | $0.38B | -0.25% |
| 2022-03-31 | $0.00B | $0.39B | 0.50% |
| 2021-12-31 | $0.01B | $0.40B | 2.00% |
| 2021-09-30 | $0.01B | $0.40B | 1.24% |
| 2021-06-30 | $0.00B | $0.40B | 0.99% |
| 2021-03-31 | $0.00B | $0.41B | 0.75% |
| 2020-12-31 | $0.00B | $0.41B | -0.57% |
| 2020-09-30 | $0.00B | $0.39B | -0.65% |
| 2020-06-30 | $0.00B | $0.38B | -0.75% |
| 2020-03-31 | $0.00B | $0.22B | 1.00% |
| 2019-12-31 | $0.00B | $0.23B | 2.31% |
| 2019-09-30 | $0.01B | $0.23B | 7.05% |
| 2019-06-30 | $0.01B | $0.12B | 7.19% |
| 2019-03-31 | $0.01B | $0.11B | 6.50% |
| 2018-12-31 | $0.01B | $0.11B | 9.55% |
| 2018-09-30 | $0.00B | $0.11B | -1.98% |
| 2018-06-30 | $0.00B | $0.11B | -0.99% |
| 2018-03-31 | $0.00B | $0.10B | -3.01% |
| 2017-12-31 | $0.00B | $0.09B | -3.02% |
| 2017-09-30 | $0.01B | $0.11B | 11.06% |
| 2017-06-30 | $0.01B | $0.10B | 11.49% |
| 2017-03-31 | $0.01B | $0.10B | 11.89% |
| 2016-12-31 | $0.01B | $0.09B | 12.32% |
| 2016-09-30 | $0.01B | $0.09B | 12.79% |
| 2016-06-30 | $0.01B | $0.09B | 13.21% |
| 2016-03-31 | $0.01B | $0.09B | 14.95% |
| 2015-12-31 | $0.01B | $0.08B | 12.94% |
| 2015-09-30 | $0.01B | $0.08B | 12.00% |
| 2015-06-30 | $0.01B | $0.08B | 13.75% |
| 2015-03-31 | $0.01B | $0.07B | 12.81% |
| 2014-12-31 | $0.01B | $0.07B | 14.71% |
| 2014-09-30 | $0.01B | $0.07B | 15.44% |
| 2014-06-30 | $0.01B | $0.07B | 14.63% |
| 2014-03-31 | $0.01B | $0.06B | 15.38% |
| 2013-12-31 | $0.01B | $0.06B | 16.14% |
| 2013-09-30 | $0.01B | $0.06B | 16.82% |
| 2013-06-30 | $0.01B | $0.05B | 17.56% |
| 2013-03-31 | $0.01B | $0.05B | 18.27% |
| 2012-12-31 | $0.01B | $0.05B | 17.02% |
| 2012-09-30 | $0.01B | $0.05B | 17.78% |
| 2012-06-30 | $0.01B | $0.05B | 18.60% |
| 2012-03-31 | $0.01B | $0.04B | 19.51% |
| 2011-12-31 | $0.01B | $0.04B | 20.51% |
| 2011-09-30 | $0.01B | $0.04B | 18.92% |
| 2011-06-30 | $0.01B | $0.04B | 17.02% |
| 2011-03-31 | $0.01B | $0.04B | 14.81% |
| 2010-12-31 | $0.00B | $0.03B | 12.31% |
| 2010-09-30 | $0.00B | $0.03B | 12.70% |
| 2010-06-30 | $0.00B | $0.03B | 13.11% |
| 2010-03-31 | $0.00B | $0.03B | 13.56% |
| 2009-12-31 | $0.00B | $0.03B | 13.91% |
| 2009-09-30 | $0.00B | $0.03B | 14.29% |
| 2009-06-30 | $0.00B | $0.03B | 14.68% |
| 2009-03-31 | $0.00B | $0.03B | 15.09% |
| 2008-12-31 | $0.00B | $0.03B | 15.69% |
| 2008-09-30 | $0.00B | $0.03B | 16.33% |
| 2008-06-30 | $0.00B | $0.03B | 17.02% |
| 2008-03-31 | $0.00B | $0.02B | 17.78% |
| 2007-12-31 | $0.00B | $0.02B | 18.39% |
| 2007-09-30 | $0.00B | $0.02B | 19.05% |
| 2007-06-30 | $0.00B | $0.02B | 19.75% |
| 2007-03-31 | $0.00B | $0.02B | 20.25% |
| 2006-12-31 | $0.00B | $0.02B | 21.92% |
| 2006-09-30 | $0.00B | $0.02B | 23.53% |
| 2006-06-30 | $0.00B | $0.02B | 25.00% |
| 2006-03-31 | $0.00B | $0.02B | 26.23% |
| 2005-12-31 | $0.00B | $0.02B | 26.23% |
| 2005-09-30 | $0.00B | $0.02B | 26.23% |
| 2005-06-30 | $0.00B | $0.02B | 25.81% |
| 2005-03-31 | $0.00B | $0.02B | 25.81% |
| 2004-12-31 | $0.00B | $0.02B | 25.81% |
| 2004-09-30 | $0.00B | $0.02B | 25.81% |
| 2004-06-30 | $0.00B | $0.02B | 26.23% |
| 2004-03-31 | $0.00B | $0.02B | 26.67% |
| 2003-12-31 | $0.00B | $0.02B | 27.12% |
| 2003-09-30 | $0.00B | $0.02B | 27.59% |
| 2003-06-30 | $0.00B | $0.02B | 27.59% |
| 2003-03-31 | $0.00B | $0.01B | 21.05% |
| 2002-12-31 | $0.00B | $0.01B | 14.04% |
| 2002-09-30 | $0.00B | $0.02B | 7.02% |
| 2002-06-30 | $0.00B | $0.01B | 7.27% |
| 2002-03-31 | $0.00B | $0.01B | 7.41% |
| 2001-12-31 | $0.00B | $0.01B | 10.00% |
| 2001-09-30 | $0.00B | $0.01B | 10.26% |
| 2001-06-30 | $0.00B | $0.01B | 10.26% |
| 2001-03-31 | $0.00B | 20.51% | |
| 2000-12-31 | $0.00B | $0.01B | 23.08% |
| 2000-09-30 | $0.00B | $0.01B | 31.37% |
| 2000-06-30 | $0.00B | $0.01B | 24.49% |
| 2000-03-31 | $0.00B | $0.01B | 16.67% |
| 1999-12-31 | $0.00B | $0.01B | 17.02% |
| 1999-09-30 | $0.00B | $0.01B | 22.86% |
| 1999-06-30 | $0.00B | $0.01B | 50.00% |
| 1999-03-31 | $0.00B | $0.01B | 100.00% |
| 1998-12-31 | $0.00B | 0.00% | |
| 1998-09-30 | $0.00B | 0.00% | |
| 1998-06-30 | $0.00B | 0.00% | |
| 1998-03-31 | $0.00B | 0.00% | |
| 1997-12-31 | $0.00B | 0.00% | |
| 1997-09-30 | $0.00B | 0.00% | |
| 1997-06-30 | $0.00B | 44.44% | |
| 1997-03-31 | $0.00B | 44.44% | |
| 1996-12-31 | $0.00B | 0.00% | |
| 1996-09-30 | $0.00B | $0.01B | 0.00% |
| 1996-06-30 | $0.00B | 0.00% | |
| 1996-03-31 | $0.00B | 0.00% | |
| 1995-12-31 | $0.00B | $0.01B | 0.00% |
| 1995-09-30 | $0.00B | $0.00B | 0.00% |
| 1995-06-30 | $0.00B | $0.01B | 0.00% |
| 1995-03-31 | $0.00B | $0.01B | 0.00% |
| 1994-12-31 | $0.00B | $0.01B | 0.00% |
| 1994-09-30 | $0.00B | $0.01B | 0.00% |
| 1994-06-30 | $0.00B | $0.01B | 0.00% |
| 1994-03-31 | $0.00B | $0.01B | 0.00% |
| 1993-12-31 | $0.00B | $0.01B | 0.00% |
| 1993-09-30 | $0.00B | $0.01B | 0.00% |
| 1993-06-30 | $0.00B | $0.01B | 0.00% |
| 1993-03-31 | $0.00B | $0.00B | 0.00% |
| 1992-12-31 | $0.00B | $0.00B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.429B | $0.241B |
| MESA LABORATORIES, INC. designs, develops, acquires, manufactures and markets instruments and systems utilized in connection with industrial applications and hemodialysis therapy. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $215.010B | 25.55 |
| Intuitive Surgical (ISRG) | United States | $194.409B | 76.06 |
| IDEXX Laboratories (IDXX) | United States | $56.231B | 55.85 |
| Edwards Lifesciences (EW) | United States | $48.211B | 32.33 |
| Alcon (ALC) | Switzerland | $38.868B | 26.27 |
| IQVIA Holdings (IQV) | United States | $37.851B | 21.11 |
| Mettler-Toledo (MTD) | United States | $28.470B | 33.31 |
| DexCom (DXCM) | United States | $26.115B | 36.00 |
| STERIS (STE) | Ireland | $24.712B | 25.51 |
| Waters (WAT) | United States | $22.941B | 30.34 |
| Hologic (HOLX) | United States | $16.718B | 17.56 |
| SONOVA HOLDING (SONVY) | Switzerland | $14.969B | 0.00 |
| Penumbra (PEN) | United States | $12.219B | 85.96 |
| Globus Medical (GMED) | United States | $11.604B | 24.35 |
| Masimo (MASI) | United States | $7.431B | 23.81 |
| Glaukos (GKOS) | United States | $6.253B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $5.835B | 18.54 |
| Teleflex (TFX) | United States | $5.607B | 8.94 |
| TransMedics (TMDX) | United States | $4.333B | 51.33 |
| LivaNova (LIVN) | United Kingdom | $3.427B | 18.51 |
| Veracyte (VCYT) | United States | $3.386B | 38.60 |
| Alphatec Holdings (ATEC) | United States | $2.965B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.548B | 11.96 |
| Elekta AB (EKTAY) | Sweden | $2.183B | 20.42 |
| Artivion (AORT) | United States | $2.138B | 98.09 |
| PROCEPT BioRobotics (PRCT) | United States | $2.011B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $1.826B | 15.94 |
| UFP Technologies (UFPT) | United States | $1.692B | 22.35 |
| Tandem Diabetes Care (TNDM) | United States | $1.450B | 0.00 |
| AxoGen (AXGN) | United States | $1.402B | 0.00 |
| Beta Bionics (BBNX) | United States | $1.310B | 0.00 |
| IRadimed (IRMD) | United States | $1.224B | 58.32 |
| OPKO Health (OPK) | United States | $1.059B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.045B | 5.66 |
| Pulse Biosciences (PLSE) | United States | $0.965B | 0.00 |
| SiBone (SIBN) | United States | $0.807B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.640B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.621B | 36.13 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.613B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.545B | 10.88 |
| AngioDynamics (ANGO) | United States | $0.541B | 0.00 |
| NeuroPace (NPCE) | United States | $0.539B | 0.00 |
| RxSight (RXST) | United States | $0.519B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.441B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.428B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.428B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.366B | 61.00 |
| ClearPoint Neuro (CLPT) | United States | $0.361B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.275B | 2.05 |
| Spectral Diagnostics (EDTXF) | Canada | $0.269B | 0.00 |
| CVRx (CVRX) | United States | $0.221B | 0.00 |
| 908 Devices (MASS) | United States | $0.216B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.211B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.205B | 0.00 |
| Inogen (INGN) | United States | $0.192B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.178B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.162B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.161B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.160B | 0.00 |
| Solana (HSDT) | United States | $0.139B | 0.00 |
| LENSAR (LNSR) | United States | $0.137B | 0.00 |
| Accuray (ARAY) | United States | $0.120B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.109B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.108B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.107B | 0.00 |
| Neuronetics (STIM) | United States | $0.104B | 0.00 |
| Hyperfine (HYPR) | United States | $0.097B | 0.00 |
| InspireMD (NSPR) | United States | $0.083B | 0.00 |
| DarioHealth (DRIO) | United States | $0.080B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.073B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.063B | 0.00 |
| Positron (POSC) | United States | $0.050B | 0.00 |
| Spectral AI (MDAI) | United States | $0.049B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.037B | 0.00 | |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Envoy Medical (COCH) | United States | $0.023B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.017B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.015B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.014B | 0.00 |
| Tenon Medical (TNON) | United States | $0.013B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.35 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |